Invention Grant
- Patent Title: Quinoline potassium channel inhibitors
- Patent Title (中): 喹啉钾通道抑制剂
-
Application No.: US10571841Application Date: 2004-09-17
-
Publication No.: US07692017B2Publication Date: 2010-04-06
- Inventor: Christopher J. Dinsmore , Jeffrey M. Bergman
- Applicant: Christopher J. Dinsmore , Jeffrey M. Bergman
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Heidi M. Struse; Mark R. Daniel; Richard S. Parr
- International Application: PCT/US2004/030485 WO 20040917
- International Announcement: WO2005/030129 WO 20050407
- Main IPC: C07D215/00
- IPC: C07D215/00 ; C07D215/38 ; C07D215/12
Abstract:
The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
Public/Granted literature
- US20070043042A1 Quinoline potassium channel inhibitors Public/Granted day:2007-02-22
Information query
